Phosphor‐signal transducers and activator of transcription 1 signaling in mucosal lichen planus developing from metastatic bladder cancer treated with pembrolizumab
- 28 April 2021
- journal article
- letter
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 34 (4), e14961
- https://doi.org/10.1111/dth.14961
Abstract
Click on the article title to read more.Keywords
This publication has 8 references indexed in Scilit:
- Cutaneous immune‐related adverse events in patients with melanoma treated with checkpoint inhibitorsBritish Journal of Dermatology, 2021
- Treatment trends in oral lichen planus and oral lichenoid lesions (Review)Experimental and Therapeutic Medicine, 2020
- Nivolumab-related lichen planus of the lip in a patient with head and neck cancerOral Oncology, 2020
- Mucosal Lichen Planus Mimicking Mucosal Lesions in Stevens-Johnson Syndrome after Nivolumab TherapyActa Dermato-Venereologica, 2019
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunityNature, 2017
- Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapyEuropean Journal of Cancer, 2016
- Pembrolizumab for the Treatment of Non–Small-Cell Lung CancerThe New England Journal of Medicine, 2015
- Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularisBritish Journal of Dermatology, 2011